Free Trial

Janux Therapeutics (JANX) News Today

Janux Therapeutics logo
$23.90 +0.20 (+0.84%)
As of 10:27 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

JANX Latest News

Janux Therapeutics, Inc. stock logo
Millennium Management LLC Invests $6.22 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)
Millennium Management LLC purchased a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 116,102 shares of the company's st
Janux Therapeutics, Inc. stock logo
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Has $22.99 Million Stock Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)
Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. lessened its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 9.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 429,392 shares of the company's
Janux Therapeutics, Inc. stock logo
Woodline Partners LP Buys 251,924 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Woodline Partners LP grew its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 15.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,852,187 shares of the company's stock after acquiring an additiona
Janux Therapeutics, Inc. stock logo
Rafferty Asset Management LLC Sells 13,522 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Rafferty Asset Management LLC decreased its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 20.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 52,168 shares of the company's stock after selling 13,522 shares during the period. R
Janux Therapeutics, Inc. stock logo
Janux Therapeutics, Inc. (NASDAQ:JANX) Given Average Rating of "Buy" by Analysts
Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) has earned an average rating of "Buy" from the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and two
Janux Therapeutics, Inc. stock logo
Deutsche Bank AG Purchases 73,912 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Deutsche Bank AG boosted its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 386.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 93,029 shares of the company's stock after buying an additional 73,9
Janux Therapeutics, Inc. stock logo
Troluce Capital Advisors LLC Buys New Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)
Troluce Capital Advisors LLC bought a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 32,297 shares of the company's st
Janux Therapeutics, Inc. stock logo
50,000 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Purchased by Tang Capital Management LLC
Tang Capital Management LLC purchased a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 50,000 shares of the company's stock, valued at appro
Janux Therapeutics, Inc. stock logo
Point72 Asset Management L.P. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)
Point72 Asset Management L.P. boosted its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 57.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 621,383 shares of the company's stock after buying
Janux Therapeutics, Inc. stock logo
Sphera Funds Management LTD. Takes Position in Janux Therapeutics, Inc. (NASDAQ:JANX)
Sphera Funds Management LTD. bought a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 68,333 shares of the company's stoc
Janux Therapeutics, Inc. stock logo
Lazard Asset Management LLC Buys New Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)
Lazard Asset Management LLC purchased a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 82,005 shares of the company's stock, valued at approxim
Janux Therapeutics, Inc. stock logo
Janux Therapeutics, Inc. (NASDAQ:JANX) is Prosight Management LP's 10th Largest Position
Prosight Management LP increased its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 60.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 329,768 shares of the company's stock after purchasing an additional 1
Janux Therapeutics, Inc. stock logo
Bank of America Corp DE Purchases 731,962 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Bank of America Corp DE grew its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 1,165.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 794,761 shares of the company's stock after purchasing
Janux Therapeutics, Inc. stock logo
Northern Trust Corp Buys 42,302 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Northern Trust Corp boosted its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 15.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 308,800 shares of the company's stock afte
Janux Therapeutics, Inc. stock logo
MPM Bioimpact LLC Raises Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)
MPM Bioimpact LLC boosted its holdings in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 34.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 230,000 shares of the company's stock after acquiring an
Janux Therapeutics, Inc. stock logo
Janux Therapeutics, Inc. (NASDAQ:JANX) is Paradigm Biocapital Advisors LP's 5th Largest Position
Paradigm Biocapital Advisors LP boosted its holdings in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 46.5% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,515,986 shares of the company's stock after acquir
Janux Therapeutics, Inc. stock logo
Nicholas Investment Partners LP Invests $2.73 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)
Nicholas Investment Partners LP bought a new position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 50,958 shares of the company's stock, valued a
Janux Therapeutics, Inc. stock logo
Research Analysts Offer Predictions for JANX FY2025 Earnings
Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Cantor Fitzgerald boosted their FY2025 earnings estimates for shares of Janux Therapeutics in a report issued on Monday, May 12th. Cantor Fitzgerald analyst J. Schimmer now expects that the company will post earnings per share of ($3.28) for
Janux Therapeutics, Inc. stock logo
Leerink Partnrs Issues Optimistic Outlook for JANX Earnings
Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Equities researchers at Leerink Partnrs lifted their Q2 2025 earnings per share (EPS) estimates for Janux Therapeutics in a note issued to investors on Monday, May 12th. Leerink Partnrs analyst J. La. Rosa now forecasts that the company will
Janux Therapeutics, Inc. stock logo
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Orbimed Advisors LLC
Orbimed Advisors LLC reduced its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 39.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 758,566 shares of the company's stock after selling
Janux Therapeutics, Inc. stock logo
Integral Health Asset Management LLC Invests $10.71 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)
Integral Health Asset Management LLC acquired a new position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 200,000 shares of the company's stock, valued at approximately $10,708,
Janux Therapeutics, Inc. stock logo
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Janus Henderson Group PLC
Janus Henderson Group PLC boosted its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 41.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,562,402 shares of the company's st
Janux Therapeutics, Inc. stock logo
40,349 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Purchased by Cubist Systematic Strategies LLC
Cubist Systematic Strategies LLC bought a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 40,349 shares of the company's stock
Janux Therapeutics, Inc. stock logo
23,501 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Purchased by Fred Alger Management LLC
Fred Alger Management LLC acquired a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 23,501 shares of the company's stock, valued at approximately $1,258
Janux Therapeutics, Inc. stock logo
The Manufacturers Life Insurance Company Purchases 32,917 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
The Manufacturers Life Insurance Company raised its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 107.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,512 shares of the company'
Janux Therapeutics, Inc. stock logo
Farallon Capital Management LLC Acquires Shares of 48,000 Janux Therapeutics, Inc. (NASDAQ:JANX)
Farallon Capital Management LLC acquired a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 48,000 shares of the company's stock, value
Janux Therapeutics, Inc. stock logo
Driehaus Capital Management LLC Invests $27.61 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)
Driehaus Capital Management LLC bought a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 515,646 shares of the company's stock, valued at approxi
Janux Therapeutics, Inc. stock logo
Crestline Management LP Acquires New Position in Janux Therapeutics, Inc. (NASDAQ:JANX)
Crestline Management LP bought a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 23,414 shares of the company's stock, valued at
Janux Therapeutics, Inc. stock logo
Algert Global LLC Acquires 40,489 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Algert Global LLC boosted its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 165.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 64,961 shares of the company's stock after buying an additional 40,489 shares during the perio
Janux Therapeutics, Inc. stock logo
Cutter Capital Management LP Makes New $6.43 Million Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)
Cutter Capital Management LP acquired a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 120,000 shares of the company's stock, val
Janux Therapeutics, Inc. stock logo
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down on Insider Selling
Janux Therapeutics (NASDAQ:JANX) Shares Gap Down Following Insider Selling
Janux Therapeutics, Inc. stock logo
Alyeska Investment Group L.P. Raises Stock Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)
Alyeska Investment Group L.P. grew its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 69.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 344,916 shares of the company's sto
Janux Therapeutics, Inc. stock logo
Avidity Partners Management LP Purchases 179,900 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Avidity Partners Management LP lifted its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 32.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 741,900 shares of the company's stock after purch
Janux Therapeutics, Inc. stock logo
Voya Investment Management LLC Sells 25,547 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Voya Investment Management LLC lessened its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 36.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,254 shares of the company's
Janux Therapeutics, Inc. stock logo
Janux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Ally Bridge Group NY LLC
Ally Bridge Group NY LLC reduced its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 17.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 90,292 shares of the company's stock after selling 1
Janux Therapeutics, Inc. stock logo
Schonfeld Strategic Advisors LLC Sells 39,855 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Schonfeld Strategic Advisors LLC decreased its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 26.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 109,500 shares of the company's stock after selling 39,85
Janux Therapeutics, Inc. stock logo
RA Capital Management L.P. Acquires 1,200,000 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
RA Capital Management L.P. boosted its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 13.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,365,652 shares of the company'
Janux Therapeutics, Inc. stock logo
Samsara BioCapital LLC Trims Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)
Samsara BioCapital LLC cut its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 50.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,263 shares of the company's stock af
Janux Therapeutics, Inc. stock logo
First Trust Advisors LP Makes New $6.86 Million Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)
First Trust Advisors LP acquired a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 128,062 shares of the
Janux Therapeutics, Inc. stock logo
Marshall Wace LLP Sells 25,703 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)
Marshall Wace LLP trimmed its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 53.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,348 shares of the company's stock after selling 25,7
Janux Therapeutics, Inc. stock logo
Janux Therapeutics (JANX) to Release Quarterly Earnings on Tuesday
Janux Therapeutics (NASDAQ:JANX) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-janux-therapeutics-inc-stock/)
Get Janux Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter.

JANX Media Mentions By Week

JANX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JANX
News Sentiment

1.04

0.87

Average
Medical
News Sentiment

JANX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JANX Articles
This Week

4

5

JANX Articles
Average Week

Get Janux Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:JANX) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners